MedTrace Logo

Study of Difluprednate in the Treatment of Uveitis

NCT00501579 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2008-08-29

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of difluprednate compared with prednisolone acetate in the treatment of endogenous anterior uveitis.

Conditions

  • Uveitis

Interventions

DRUG

Difluprednate

DRUG

Prednisolone Acetate

Sponsors & Collaborators

  • Sirion Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Roger Vogel, MD · Sirion Therapeutics

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00501579 on ClinicalTrials.gov